Women's Health Primary Care
Dr. Nancy E. Reid
Bacterial vaginosis (BV) is the most common vaginal infection globally and its rate of recurrence is high due to residual infection, drug resistance, or reinfection. Though the treatment for BV is straightforward, preventing recurrence is more complex. There have been multiple studies to decrease recurrent BV due to its negative emotional, sexual, and social effects as well as the economic burden on the healthcare system. This article provides an overview of current possible treatments as well as clinical trials on recurrent BV.
Sturgis O. Recurrent Bacterial Vaginosis: A Clinical Conundrum. Lynchburg Journal of Medical Science. 2021; 3(4).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.